Cargando…
Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis
BACKGROUND: The prognosis of non-small-cell lung cancer (NSCLC) has not been significantly improved. In the past several years, research on epigenetics is in full swing. There is a focus on the gene EZH2; however, its role as a predictor of the prognosis of NSCLC is in the debate. OBJECTIVE: To clar...
Autores principales: | Fan, Kui, Zhang, Chuan-long, Qi, Yuan-fu, Dai, Xin, Birling, Yoann, Tan, Zhao-feng, Cao, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705440/ https://www.ncbi.nlm.nih.gov/pubmed/33299862 http://dx.doi.org/10.1155/2020/2380124 |
Ejemplares similares
-
Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Chuan-Long, et al.
Publicado: (2022) -
The clinicopathological and prognostic significances of EZH2 expression in urological cancers: A meta‑analysis and bioinformatics analysis
por: Bai, Yang-Kai, et al.
Publicado: (2023) -
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
por: Fan, Kui, et al.
Publicado: (2022) -
Integrated Bioinformatics Analysis the Function of RNA Binding Proteins (RBPs) and Their Prognostic Value in Breast Cancer
por: Wang, Ke, et al.
Publicado: (2019) -
Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer
por: Qi, Qi, et al.
Publicado: (2021)